Xiamen Amoytop Biotech Statistics
Total Valuation
Xiamen Amoytop Biotech has a market cap or net worth of CNY 31.45 billion. The enterprise value is 30.87 billion.
Market Cap | 31.45B |
Enterprise Value | 30.87B |
Important Dates
The last earnings date was Thursday, October 24, 2024.
Earnings Date | Oct 24, 2024 |
Ex-Dividend Date | May 23, 2024 |
Share Statistics
Xiamen Amoytop Biotech has 406.80 million shares outstanding. The number of shares has increased by 1.35% in one year.
Current Share Class | n/a |
Shares Outstanding | 406.80M |
Shares Change (YoY) | +1.35% |
Shares Change (QoQ) | +0.43% |
Owned by Insiders (%) | 50.86% |
Owned by Institutions (%) | 13.54% |
Float | 110.49M |
Valuation Ratios
The trailing PE ratio is 42.47 and the forward PE ratio is 31.03. Xiamen Amoytop Biotech's PEG ratio is 1.03.
PE Ratio | 42.47 |
Forward PE | 31.03 |
PS Ratio | 12.12 |
PB Ratio | 13.89 |
P/TBV Ratio | n/a |
P/FCF Ratio | 228.49 |
P/OCF Ratio | n/a |
PEG Ratio | 1.03 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.68, with an EV/FCF ratio of 224.32.
EV / Earnings | 41.68 |
EV / Sales | 11.90 |
EV / EBITDA | 33.68 |
EV / EBIT | 36.23 |
EV / FCF | 224.32 |
Financial Position
The company has a current ratio of 4.32, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.32 |
Quick Ratio | 3.43 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | 0.07 |
Interest Coverage | 1,731.44 |
Financial Efficiency
Return on equity (ROE) is 37.46% and return on invested capital (ROIC) is 26.81%.
Return on Equity (ROE) | 37.46% |
Return on Assets (ROA) | 22.10% |
Return on Capital (ROIC) | 26.81% |
Revenue Per Employee | 1.32M |
Profits Per Employee | 377,904 |
Employee Count | 1,960 |
Asset Turnover | 1.08 |
Inventory Turnover | 0.85 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.88% in the last 52 weeks. The beta is 0.45, so Xiamen Amoytop Biotech's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | +81.88% |
50-Day Moving Average | 69.19 |
200-Day Moving Average | 60.00 |
Relative Strength Index (RSI) | 56.96 |
Average Volume (20 Days) | 2,660,194 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Xiamen Amoytop Biotech had revenue of CNY 2.60 billion and earned 740.69 million in profits. Earnings per share was 1.82.
Revenue | 2.60B |
Gross Profit | 2.42B |
Operating Income | 852.17M |
Pretax Income | 838.73M |
Net Income | 740.69M |
EBITDA | 911.20M |
EBIT | 852.17M |
Earnings Per Share (EPS) | 1.82 |
Balance Sheet
The company has 584.55 million in cash and 9.90 million in debt, giving a net cash position of 574.65 million or 1.41 per share.
Cash & Cash Equivalents | 584.55M |
Total Debt | 9.90M |
Net Cash | 574.65M |
Net Cash Per Share | 1.41 |
Equity (Book Value) | 2.26B |
Book Value Per Share | 5.57 |
Working Capital | 1.16B |
Cash Flow
In the last 12 months, operating cash flow was 421.16 million and capital expenditures -283.54 million, giving a free cash flow of 137.62 million.
Operating Cash Flow | 421.16M |
Capital Expenditures | -283.54M |
Free Cash Flow | 137.62M |
FCF Per Share | 0.34 |
Margins
Gross margin is 93.08%, with operating and profit margins of 32.84% and 28.54%.
Gross Margin | 93.08% |
Operating Margin | 32.84% |
Pretax Margin | 32.32% |
Profit Margin | 28.54% |
EBITDA Margin | 35.11% |
EBIT Margin | 32.84% |
FCF Margin | 5.30% |
Dividends & Yields
This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 0.52%.
Dividend Per Share | 0.41 |
Dividend Yield | 0.52% |
Dividend Growth (YoY) | 92.49% |
Years of Dividend Growth | 4 |
Payout Ratio | 22.52% |
Buyback Yield | -1.35% |
Shareholder Yield | -0.84% |
Earnings Yield | 2.35% |
FCF Yield | 0.44% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Xiamen Amoytop Biotech has an Altman Z-Score of 34.79.
Altman Z-Score | 34.79 |
Piotroski F-Score | n/a |